Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:03 PM
Ignite Modification Date:
2025-12-24 @ 4:03 PM
NCT ID:
NCT03271866
Eligibility Criteria:
Inclusion Criteria:
1. Meet the Diagnostic and Statistical Manual (DSM-5) diagnostic criteria for schizophrenia;
2. Duration of illness less than 5 years with current symptoms exacerbation;
3. Male and female aged 18 to 65 years;
4. PANSS total score \< 60 and CDSS-C total score \< 6;
5. Signed the study consent for participation;
6. Patients with higher risk factors for MetS, or patients who gained weight \> 10% of their pre-drug weight within the first year after antipsychotic medication.
Exclusion Criteria:
1. Having a history of substance dependence or abuse or whose symptoms are caused by other diagnosable mental disorders;
2. Having a history of traumatic brain injury, seizures, or other known neurological or organic diseases of the central nervous system;
3. Taking antidepressants, stimulants, mood stabilizers or accepting electricity shock treatment;
4. Having current suicidal or homicidal thoughts or any safety concern by research staff that cannot be managed in an inpatient setting;
5. The routine blood tests showing abnormal renal, and liver function;
6. Pregnant or lactating women.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT03271866
Study Brief:
Protocol Section:
NCT03271866